Somatic mutations of beta2-microglobulin are correlated with a lack of disease recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Wiley
2018
|